Skip to main content
103 search results for:

EULAR 2019 

sort by |
"newest" sorts results by publication date. "most relevant" also considers factors like how often the search phrase is in the result.
  1. 19-09-2019 | Teaser

    EULAR 2019

    Coverage from the 2019 European Congress of Rheumatology. Includes research news and expert commentary on the FINCH 1 and 3, and SPIRIT-H2H trials.

  2. EULAR 2019 opening plenary session

    EULAR conference 2019 rheumatology session

  3. EULAR 2019 opening plenary session

    Featuring inspiring talks and updates from EULAR, in addition to the EULAR Awards. ​​​​​​​​

  4. 26-04-2019 | Teaser
    Session recommendation

    EULAR 2019 opening plenary session

    Wednesday 12 June, 13:00–14:00, Hall 6​​​​​​​, IFEMA – Feria de Madrid, Madrid, Spain. Featuring inspiring talks and updates from EULAR, in addition to the EULAR Awards.

  5. 23-04-2019 | EULAR 2019 | Channel

    EULAR 2019

    EULAR Congress 2019- Madrid, Spain.

  6. 04-06-2022 | EULAR 2022 | Conference coverage | Article

    Support for pausing methotrexate only after second COVID-19 vaccine dose

    EULAR 2022; Copenhagen, Denmark: 1–4 June Ann Rheum Dis  2022; 81 : 208–209

  7. 01-03-2021 | COVID-19 | Feature | Article

    COVID-19 vaccination in patients with rheumatic diseases

    This includes the Oxford–AstraZeneca (ChAdOx1 nCoV-2019) vaccine, which contains a live, but non-replicating, adenovirus vector and therefore cannot cause infection and is recommended for use in people who are immunosuppressed.

  8. 22-10-2021 | Dermatomyositis | News | Article

    New EULAR/ACR dermatomyositis criteria shed light on disease frequency, mortality

    A population-based cohort study using the 2017 EULAR/American College of Rheumatology criteria for dermatomyositis has identified a higher incidence, prevalence, and associated mortality rate than previously reported.

  9. 31-08-2021 | Sjögren’s syndrome | News | Article

    Early-onset primary Sjögren’s syndrome linked to more severe disease

    Their study included 333 people who were newly diagnosed with pSS at the Hebei General Hospital in 2016–2019, of whom 10.81% were aged 35 years or younger and categorized as having early-onset pSS.

  10. 21-02-2019 | Spondyloarthropathies | Feature | Article
    Updated June 2022

    Trials of JAK inhibitors in spondyloarthritis: A round-up

    Related news story:   SELECT-AXIS 2: Upadacitinib shows promise for axSpA medwireNews is an independent medical news service provided by Springer Healthcare. © 2019 Springer Healthcare part of the Springer Nature group

  11. 07-06-2021 | EULAR 2021 | Conference coverage | Article
    News in brief

    BIOCOV study supports rituximab link to severe COVID-19

    Further research confirming an association between rituximab and an increased risk for severe COVID-19 was reported at the EULAR 2021 Virtual Congress.

  12. 05-06-2021 | EULAR 2021 | Conference coverage | Article

    Etanercept response clusters identified in patients with JIA

    And she added: “Understanding the factors underpinning these clusters would really aid stratified treatment of JIA.” medwireNews is an independent medical news service provided by Springer Healthcare Ltd. © 2021 EULAR 2021 Virtual Congress; 2–5 June

  13. 29-03-2019 | Rheumatoid arthritis | Feature | Article
    Updated July 2020

    JAK inhibitors in RA: A round-up of the phase 3 trials

    It is estimated that all data for the primary outcome will be collected by July 2019.

  14. 11-11-2020 | ACR 2020 | Conference coverage | Article

    ‘The Great Debate’: JAK inhibitors vs biologics following methotrexate failure in RA

    Accordingly, in the 2019 update of the European RA treatment guidelines, EULAR did “not specify a treatment order between biologics or [JAK inhibitors]” in RA patients with high-risk features and an inadequate response to conventional DMARD.

  15. 03-04-2020 | COVID-19 | News | Article

    Rheumatologists urge caution on chloroquine, hydroxychloroquine use for COVID-19

    Ann Intern Med 2020; doi:0.7326/M20-1223 Ann Intern Med 2020; doi:10.7326/M20-1334 Ann Rheum Dis 2019; doi:10.1136/annrheumdis-2020-217367

  16. 08-01-2020 | Psoriatic arthritis | Feature | Article
    Updated November 2020

    ​​​​​​​At a glance: Phase 3 trials of IL-17A inhibitors in PsA

    Average reductions in global EULAR-OMERACT synovitis score – an ultrasonography composite scoring system – were 9 points and 6 points, respectively.

  17. 04-06-2020 | EULAR 2020 | Conference coverage | Article
    News in brief

    ​​​​​​​TNF inhibitors linked to reduced VTE risk in RA patients

    Among 11,094 patients from the registry who started treatment with a new DMARD between 2009 and 2019 following a previous inadequate response to at least one DMARD, rates of VTE were 1.1% for the 5060 patients initiating a TNF inhibitor, 0.9% for the 2534 initiating another biologic agent, and 1.1% for the 3500 initiating a conventional DMARD.

  18. 12-06-2020 | EULAR 2020 | Conference coverage | Article

    Biologic, targeted synthetic DMARDs linked to increased herpes zoster risk

    Biologic and targeted synthetic DMARD use is associated with an elevated risk for herpes zoster in patients with rheumatoid arthritis compared with conventional synthetic DMARDs, according to research presented at the EULAR 2020 E-congress.

  19. 26-04-2019 | Teaser
    Session recommendation

    EULAR projects in clinical affairs

    Saturday 15th June, 09:00–10:50, Hall 7A​​​​​​​, IFEMA – Feria de Madrid, Madrid, Spain. Chairs –  Thomas Huizinga and Ulf Müller-Ladner Update on EULAR recommendations for the management of SLE.  Antonis Fanouriakis Sjögren’s management recommendations 2019.  Manuel Ramos-Casals Management of adult APS: recommendations from an EULAR task force.  Maria Tektonidou Update of the EULAR recommendations large vessel vasculitis management.  Bernhard Hellmich Update of the EULAR recommendation on PsA. Laure Gossec Update of the EULAR recommendations on RA. Josef S. Smolen

  20. 16-05-2019 | Teaser

    SENSCIS

    The SENSCIS investigators will present the results of their trial, published in The New England Journal of Medicine in May 2019, for EULAR 2019 attendees. Wednesday 12 June: 16:15–17:45 (Abstract OP0017)

Filter search results

Search Operators:

„ ... ... “ Finds documents with exactly this word group, in exactly this word order and spelling (e.g., "employer branding").
AND Finds documents with both search terms (e.g., sales AND bonus).
OR Finds documents with one or the other search term (e.g., porsche OR volkswagen).
Blank Space Finds documents with all search terms. Blank space is understood as AND (e.g., man robot production).
NOT Finds documents with no appearance of the word behind NOT (e.g., ford NOT "harrison ford").
COUNT(...)>n Finds documents where the search term is mentioned at least "n" times."n" may be any number (e.g., COUNT(gear)>8).
NEAR(..., ..., ) Finds documents with both search terms in any word order, permitting "n" words as a maximum distance between them. Best choose between 15 and 30 (e.g., NEAR(recruit, professionals, 20)).
* Finds documents with the search term in word versions or composites. The star * marks whether you wish them BEFORE, BEHIND, or BEFORE and BEHIND the search term (e.g., lightweight*, *lightweight, *lightweight*).
? Finds documents with the search termn in different spellings."?" allows only one character (e.g., organi?ation).
& + - Special characters are understood as AND (e.g., Miller Bros. & Sons).

You can use operators in your search query to narrow down your results even more.

Tap the operator, or hover the mouse pointer over it, to read more about how it works.